Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000899243-17-029619

Chief Legal Officer sold 15,000 shares at $20.55 ($308,250)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Dylan-Hyde Tyler Chief Legal Officer 2017-12-22 Sale −15,000 $20.55 $308,250 115,204 D: show line 1 in the form
Open-market sales · 15,000 sh · avg $20.55 · $308,250
Loading xslF345X03/doc4.xml…